Recent studies have demonstrated that USP8‐mediated deubiquitylation of TβRII promotes tumor progression and immune suppression, thereby fostering a tumor‐permissive microenvironment in pancreatic cancer. This evidence concerns the gene TGFBR2 and pancreatic neoplasm.